openPR Logo
Press release

Diabetic Neuropathy Market by Top Manufacturers – Pfizer, Inc, Johnson & Johnson, Boehringer Ingelheim GmbH., NeuroMetrix, Inc., Eli Lilly and Company, Astellas Pharma Inc

12-14-2018 06:56 AM CET | Health & Medicine

Press release from: Big Market Research

Diabetic Neuropathy Market

Diabetic Neuropathy Market

Global Diabetic Neuropathy Market to reach USD 8460.3 million by 2025. Global Diabetic Neuropathy Market valued approximately USD 4680 million in 2016 is anticipated to grow with a healthy growth rate of more than 6.80% over the forecast period 2017-2025. The growth of this market primarily driven by the ever-growing pool of geriatric population with diabetes. The rise in availability of suitable treatment options and the growing awareness on PDN catalyzes the demand for PDN drugs. With only four drugs currently approved for the management of PDN (Lyrica, Cymbalta, Nucynta and Qutenza), there arises a huge opportunity for new and emerging market players with potential pipeline portfolio. Of the marketed products analyzed, Lyrica accounted for a maximum market share in 2017 and will continue similar trend through 2026.

Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2843422?utm_source=OPR&utm_medium=AG

The recent approval of Lyrica's control release formulation in October 2017 further augments its market growth. The PDN drugs market observes a presence of strong pipeline portfolio, which would facilitate the overall growth during the forecast period from 2018 to 2026. Varoomed Co. Ltd.'s VM202 currently in phase III is the only gene therapy developed with disease modifying properties. However, the higher pricing of gene therapy could hamper the growth of VM202 in future.

With diabetes being a global concern, PDN drugs market comprises a worldwide outreach. In 2017, North America dominated the market and expected to maintain its position throughout the forecast period. Availability of approved drugs and the presence of extensive diabetic patient pool contributed to the overall market growth. Asia Pacific exhibited fastest CAGR during the forecast period due to the growing awareness of PDN and the rise in healthcare expenditure.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Disorder:
• Peripheral Neuropathy
• Autonomic Neuropathy
• Proximal Neuropathy
• Focal Neuropathy

The industry is seeming to be fairly competitive. Some of the leading market players include Pfizer, Inc, Johnson & Johnson, Boehringer Ingelheim GmbH., NeuroMetrix, Inc., Eli Lilly and Company, Astellas Pharma Inc, GlaxoSmithKline plc., Lupin Limited, Depomed, Inc., Glenmark Pharmaceuticals Ltd., Arbor Pharmaceuticals, LLC and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Get a discount on this research report @ https://www.bigmarketresearch.com/request-for-discount/2843422?utm_source=OPR&utm_medium=AG
TABLE OF CONTENTS
Chapter 1.Global Diabetic Neuropathy Market Definition and Scope
1.1.Research Objective
1.2.Market Definition
1.3.Scope of The Study
1.4.Years Considered for The Study
1.5.Currency Conversion Rates
1.6.Report Limitation
Chapter 2.Research Methodology
2.1.Research Process
2.1.1.Data Mining
2.1.2.Analysis
2.1.3.Market Estimation
2.1.4.Validation
2.1.5.Publishing
2.2.Research Assumption
Chapter 3.Executive Summary
3.1.Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2.Key Trends
Chapter 4.Global Diabetic Neuropathy Market Dynamics
4.1.Growth Prospects
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.2.Industry Analysis
4.2.1.Porters 5 Force Model
4.2.2.PEST Analysis
4.2.3.Value Chain Analysis
4.3.Analyst Recommendation & Conclusion
Chapter 5.Global Diabetic Neuropathy Market, By Type of Disorder
5.1.Market Snapshot
5.2.Market Performance - Potential Model
5.3.Global Diabetic Neuropathy Market, Sub Segment Analysis
5.3.1.Peripheral Neuropathy
5.3.1.1.Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2.Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.Autonomic Neuropathy
5.3.2.1.Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2.Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.Proximal Neuropathy
5.3.3.1.Market estimates & forecasts, 2015-2025 (USD Billion)

Inquiry before Buy @ https://www.bigmarketresearch.com/purchase-enquiry/2843422?utm_source=OPR&utm_medium=AG

About Us:
Industry executives tend to keep a tab on their business competitors. This keeps them updated on strategic business activities and investment trends. Company profiles are crucial to participating players of interconnected verticals.

5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Call answer Direct: +1-971-202-1575
Call answer Toll Free: +1-800-910-6452
Email help@bigmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Neuropathy Market by Top Manufacturers – Pfizer, Inc, Johnson & Johnson, Boehringer Ingelheim GmbH., NeuroMetrix, Inc., Eli Lilly and Company, Astellas Pharma Inc here

News-ID: 1439937 • Views: 338

More Releases from Big Market Research

Transient Elastography Devices Market 2020 Analyzed by Top Key Players Echosens, …
Big Market Research provides a detailed overview of Transient Elastography Devices Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Transient Elastography Devices market in conjunction with the geographical landscape, demand spectrum, remuneration scale, and growth graph of this vertical have also been included during this report. This report is a professional and thorough research of the world Transient Elastography Devices
Augmented Reality in Retail Market Emerging Trends, Global Demand and Top Brands …
Global Augmented Reality in Retail Market is valued approximately at USD 10.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 46.6% over the forecast period 2020-2027. The Augmented Reality in Retail Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2027. The Augmented Reality in Retail market report is a valuable source of data for business strategists. It provides the industry
Aseptic Sampling Market in Global Industry: Demands, Insights, Research and Fore …
Global Aseptic Sampling Market is valued approximately USD 0.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.10 % over the forecast period 2020-2027. Big Market Research provides a detailed overview of Aseptic Sampling Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Aseptic Sampling market in conjunction with the geographical landscape,
3D Motion Capture System Market in Global Industry: Demands, Insights, Research …
The research report on 3D Motion Capture System Market thoroughly investigates historical data of this business sphere to lay out the future roadmap of the industry. The study attempts to predict a long-term picture of the market scenario with respect to the various growth indicators, hindrances, and opportunities that determine the industry expansion. Moreover, the report provides an exhaustive synopsis of the industry at a global and regional level. In

All 5 Releases


More Releases for Neuropathy

Diabetic Neuropathy Market Opportunity Analysis, 2018-2026
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Diabetic Neuropathy Market Opportunity Analysis, 2018-2026
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Diabetic Neuropathy Market - Global Industry Analysis 2024
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population
Diabetic Neuropathy Market - Global Industry Analysis 2025
Market Overview Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy - Pipeline Review, H1 2017, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type of neuropathy occurring in the arms, hands, legs and feet is known as diabetic peripheral neuropathy. Symptoms include numbness or tingling in the feet pain or discomfort in the feet or legs-including prickly,
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2017
ReportsWeb.com has announced the addition of the “Diabetic Peripheral Neuropathy - Pipeline Review, H1 2017” this report provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type of neuropathy occurring in the arms, hands, legs and feet is known as diabetic peripheral neuropathy. Symptoms include numbness or tingling in the feet pain or discomfort in the feet or legs-including